[Intermediators of the Krebs cycle and electron acceptor systems as new cardiac agents].
D000818:Animals; D016227:Benzoquinones; D002317:Cardiovascular Agents; D002952:Citric Acid Cycle; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy; D004579:Electron Transport / Q000187:drug effects; D000860:Hypoxia / Q000188:drug therapy; D008293:Malates / Q000627:therapeutic use*; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D011809:Quinones / Q000627:therapeutic use*; D051381:Rats; D013386:Succinates / Q000627:therapeutic use*; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000627:therapeutic use
D016227:Benzoquinones; D002317:Cardiovascular Agents; D008293:Malates; D011809:Quinones; D013386:Succinates; D014451:Ubiquinone; C001341:hexahydroubiquinone-4; C004532:quinone
Intermediaty tsikla Krebsa i élektronaktseptornye sistemy kak novye kardiofarmakologicheskie sredstva.